BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38301858)

  • 1. FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC.
    Khan AJ; Man S; Abbas M; Liu S; Zhang F
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130577. PubMed ID: 38301858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
    Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
    Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
    Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Knockdown of IGF2BP2 inhibits colorectal cancer cell proliferation, migration and promotes tumor immunity by down-regulating MYC expression].
    Liu T; Han C; Hu C; Mao S; Sun Y; Yang S; Yang K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):303-310. PubMed ID: 37087547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
    Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
    Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC dysfunction modulates stemness and tumorigenesis in breast cancer.
    Liu Y; Zhu C; Tang L; Chen Q; Guan N; Xu K; Guan X
    Int J Biol Sci; 2021; 17(1):178-187. PubMed ID: 33390842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
    Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
    Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.
    Wang F; Qiao Y; Yu J; Ren X; Wang J; Ding Y; Zhang X; Ma W; Ding Y; Liang L
    PLoS One; 2013; 8(6):e65495. PubMed ID: 23826080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
    Lu H; Yao B; Wen X; Jia B
    BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
    Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
    Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells.
    AlSultan D; Kavanagh E; O'Grady S; Eustace AJ; Castell A; Larsson LG; Crown J; Madden SF; Duffy MJ
    Invest New Drugs; 2021 Apr; 39(2):587-594. PubMed ID: 33052557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
    Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
    Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
    Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
    BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
    Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop.
    Ma F; Liu X; Zhou S; Li W; Liu C; Chadwick M; Qian C
    Cancer Lett; 2019 May; 450():63-75. PubMed ID: 30771425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
    Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
    Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.